Concepedia

Douglas C. Marchion

DC

40

Publications

3.2K

Citations

26

H-Index

1999

Active since

Affiliations

Moffitt Cancer Center(Current)

University of California, San Francisco

Molecular Oncology (United States)

Douglas C. Marchion is an author at Moffitt Cancer Center specializing in medicine, cell biology, and oncology.

Top concepts

Publications per year

1999–2023

40

Publications

40

IgA transcytosis and antigen recognition govern ovarian cancer immunity

Subir Biswas, Gunjan Mandal, Kyle K. Payne et al. · Nature · 2021 · 225 citations · Full text

Phase I Trial of Histone Deacetylase Inhibition by Valproic Acid Followed by the Topoisomerase II Inhibitor Epirubicin in Advanced Solid Tumors: A Clinical and Translational Study

Pamela N. Münster, Douglas C. Marchion, Elona Biçaku et al. · Journal of Clinical Oncology · 2007 · 218 citations · Full text

Valproic Acid Alters Chromatin Structure by Regulation of Chromatin Modulation Proteins

Douglas C. Marchion, Elona Biçaku, Adil Daud et al. · Cancer Research · 2005 · 216 citations · Full text

Sequence‐specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid

Douglas C. Marchion, Elona Biçaku, Adil Daud et al. · Journal of Cellular Biochemistry · 2004 · 185 citations

ABCG2 expression, function, and promoter methylation in human multiple myeloma

Joel G. Turner, Jana Gump, Chunchun Zhang et al. · Blood · 2006 · 185 citations · Full text

Rows per page

1–5 of 40